Tag: Hepatitis C drugs

Battle of the Brands: Gilead Sciences Inc. vs. Merck & Co. Inc

The legal dispute between the two pharmaceutical majors Gilead Sciences Inc. and Merck & Co. Inc. involving Hepatitis C drugs clearly indicates the high stakes involved when it comes to intellectual property. It all began in 2013, back in the day when Gilead Sciences Inc, filed for a New Drug application (NDA) with the FDA … Continue reading Battle of the Brands: Gilead Sciences Inc. vs. Merck & Co. Inc

Read more »